PRISM MarketView Highlights Work of Emerging Companies on
PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day...
Source: globenewswire.com
Page 19 - Priority Review News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Priority Review. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Priority Review Today - Breaking & Trending Today
Pembrolizumab Plus Chemotherapy Under Review for Primary Advanced or Recurrent Endometrial Cancer
The sBLA is supported by data from the phase 3 NRG-GY018 trial, which included patients with stage III-IV or recurrent endometrial carcinoma whose cancer was either pMMR or dMMR.
Source: oncologynurseadvisor.com
20 Highest-Grossing Biotech Stocks: Giants Driving Innovation and Growth
Biotech stocks offers the potential for significant returns driven by breakthrough discoveries and advancements in healthcare, agriculture, and other industries.
Source: ibtimes.com
Why Is Applied Therapeutics Stock Trading Higher Today? - Applied Therapeutics (NASDAQ:APLT)
Applied Therapeutics surges as FDA grants Priority Review to govorestat (AT-007) for Galactosemia treatment. If approved, it would be the first medication for Galactosemia. APLT also submits MAA to EMA, with a decision expected in Q4 2024. Private placement of $100 million.
Source: benzinga.com
Dupilumab Earns FDA Priority Review for Add-On COPD Care
The first new COPD treatment in a decade showed safety and effectiveness in a subset of patients with type 2 inflammation.
Source: medscape.com